News
Neoadjuvant immunotherapy shows promise for resectable CSCC
- Author:
- Jim Kling
Response to treatment may lead to a reduction in potentially disfiguring surgeries.
News
Weight gain linked to cancer survival in men and women
- Author:
- Jim Kling
The finding underscores the need for nutritional support emphasized in 2020 ASCO guidelines.
News
High BMI linked to better survival for cancer patients treated with ICI, but for men only
- Author:
- Jim Kling
The reasons behind the findings and implications for treatment are unknown, as is whether it applies to patients with specific cancers.
News
Early trial supports hypofractionated radiotherapy in uterine cancer
- Author:
- Jim Kling
Early toxicity results are encouraging, but long-term efficacy and safety remain unknown.
News
Time to cancer diagnoses in U.S. averages 5 months
- Author:
- Jim Kling
Diagnosis time varied significantly across tumor types, as well as within the same tumor type.
News
BRAF/MEK combo shows long-term efficacy in melanoma
- Author:
- Jim Kling
Despite positive results, immunotherapy likely remains the best choice for first-line treatment of BRAFV600 mutated advanced melanoma.
News
Annual screening benefits people at high-risk for pancreatic cancer
- Author:
- Jim Kling
Opponents of screening suggested while screening may identify cancer earlier, it doesn’t necessarily improve outcomes.
News
In NSCLC, not all EGFR mutations are the same
- Author:
- Jim Kling
Patients with the Ex20 insertion may buck trend by responding well to ICIs.
News
In early NSCLC, comorbidities linked to survival
- Author:
- Jim Kling
Respiratory and cardiometabolic comorbidities were associated with significantly worse overall survival in lung cancer.
News
Gene mutations may drive lung cancer in never-smokers
- Author:
- Jim Kling
Study hints at mechanistic differences between small cell lung cancer in smokers versus nonsmokers.
News
Usefulness of IBD biomarker may vary based on microbiome
- Author:
- Jim Kling
Microbiome-based calibration could improve sensitivity and specificity, which could improve efforts to monitor disease activity.
News
Inhibiting adenosine pathways may be key to CRC treatment
- Author:
- Jim Kling
New research suggests mechanisms behind how adenosine leads to immunosuppression in the tumor microenvironment.
News
Shortened radiotherapy for endometrial cancer looks safe, questions remain
- Author:
- Jim Kling
Early toxicity results are encouraging, but long-term efficacy and safety remain unknown.
News
Checkpoint inhibitor combos show promise in advanced RCC
- Author:
- Jim Kling
Authors of a systematic review suggest the combinations should be widely available as first-line treatment.
News
New model could boost BE screening, early diagnosis
- Author:
- Jim Kling
The predictive model relies on factors readily available in EHRs and could potentially be automated using e-Trigger tools.